| Fracture of the lower limb (820–829) | | 9.05% (7.83% to 10.81%) | 2.00% (1.96% to 2.02%) | <0.05 | Normal delivery and other indications for care in pregnancy, labour and delivery (650–659) | 9.15% (8.58% to 9.73%) | 4.64% (4.58% to 4.69%) | <0.05 |
| Ischaemic heart disease (410–414) | | 5.59% (4.48% to 6.87%) | 1.22% (1.19% to 1.24%) | <0.05 | Ischaemic heart disease (410–414) | 8.02% (7.49% to 8.57%) | 3.03% (2.98% to 3.07%) | <0.05 |
| Appendicitis (540–543) | | 3.93% (3.00% to 5.03%) | 0.75% (0.73% to 0.77%) | <0.05 | Fracture of the lower limb (820–829) | 2.42% (2.12% to 2.74%) | 0.03% (0.02% to 0.03%) | <0.05 |
| Pneumonia and influenza (480–487) | | 2.13% (1.46% to 2.99%) | 1.37% (1.34% to 1.39%) | <0.05 | Other forms of heart disease (420–429) | 1.25% (1.04% to 1.49%) | 0.22% (0.21% to 0.23%) | <0.05 |
| Normal delivery, and other indications for care in pregnancy, labour and delivery (650–659) | | 2.00% (1.35% to 2.83%) | 1.81% (1.77% to 1.83%) | 0.289 | Radiotherapy and chemotherapy | 1.21% (1.00–1.44%) | – | – |
| Cerebrovascular disease (430–438) | | 1.93% (1.29% to 2.75%) | 0.96% (0.93% to 0.98%) | <0.05 | Appendicitis (540–543) | 1.02% (0.82% to 1.23%) | 0.03% (0.03% to 0.03%) | <0.05 |
| Other forms of heart disease (420–429) | | 1.80% (1.18% to 2.60%) | 1.93% (1.90% to 1.96%) | 0.351 | Cerebrovascular disease (430–438) | 0.78% (0.61% to 0.97%) | – | – |
| Disorders of the eye and adnexa (360–379) | | 0.13% (0.01% to 0.48%) | 6.86% (6.79% to 6.91%) | <0.05 | Fracture of the upper limb (810–819) | 0.70% (0.54% to 0.88%) | – | – |
| Chronic obstructive pulmonary disease and allied conditions (490–496) | | 1.26% (0.76% to 1.96%) | 2.24% (2.20% to 2.27%) | <0.05 | Malignant neoplasm of bone, connective tissue, skin and breast (170–176) | 0.47% (0.34% to 0.62%) | 0.58% (0.55% to 0.59%) | 0.0763 |
| Hernia of the abdominal cavity (550–553) | | 0.7% (0.00% to 0.37%) | 1.83% (1.80% to 1.86%) | <0.05 | Other diseases of respiratory system (510–519) | 0.45% (0.32% to 0.60%) | 1.13% (1.10% to 1.15%) | <0.05 |
| General symptoms (780–789) | | 1.60% (1.02% to 2.36%) | 1.78% (1.74% to 1.80%) | 0.299 | Diseases of the veins and lymphatics, and other diseases of the circulatory system (451–459) | 0.44% (0.31% to 0.58%) | 0.65% (0.63% to 0.67%) | <0.05 |
| Acute respiratory infections (460–466) | | 1.06% (0.61% to 1.72%) | 1.59% (1.55% to 1.61%) | 0.052 | Neoplasms of unspecified nature (239) | 0.42% (0.29% to 0.56%) | 0.82% (0.79% to 0.84%) | <0.05 |
| Arthropathies and related disorders (710–719) | | – | 1.53% (1.50% to 1.56%) | 0.01 | Persons seeking health services for specific procedures and aftercare (V50–V59) | 0.35% (0.24% to 0.48%) | 0.57% (0.55% to 0.59%) | <0.05 |
| Other diseases of the digestive system (570–579) | | 0.79% (0.41% to 1.35%) | 1.52% (1.49% to 1.55%) | <0.05 | Symptoms (780–789) | – | 0.75% (0.73% to 0.77%) | – |
| Diseases of veins and lymphatics, and other diseases of the circulatory system (451–459) | | 0.07% (0.00% to 0.37%) | 1.52% (1.4% to 1.54%) | <0.05 | Disorders of the eye and adnexa (360–379) | – | 0.69% (0.66% to 0.70%) | – |
| Total patients included in these diagnoses | | 31.40% | 30.56% | | Total patients included in these diagnoses | 38.19% | 17.78% | |
| Total patients (2003) | | 1503 | 712 901 | | Total patients (2003) | 9835 | 630 577 | |